Esophagus - Cancer

JANS Article

Clinical T2 N0 M0 Esophageal Cancer: Identifying Predictive Factors of Upstaging

June 27, 2024 | Jo Chikwe

Of 1,579 patients undergoing esophagectomy for esophageal cancer, 60 patients underwent up-front surgery for cT2 N0 M0 esophageal cancer, of whom 8 (13 percent) were found to have pathologic T2 N0 M0, 16 (27 percent)...

JANS Article

Thoracic Surgical Oncology Group: An American Association for Thoracic Surgery Clinical Trials Initiative

June 13, 2024 | Mujtaba MubashirGold Contributor

This editorial summarizes the landscape that led to the founding of the Thoracic Surgical Oncology Group in 2017, in an era when, due to various oncology group reorganizations, a need...

JANS Article

Recovery of Patient-Reported Quality of Life After Esophagectomy

April 13, 2023 | Cameron LindSilver Contributor

This study aimed to measure the quality of life (QOL) as reported by patients after esophagectomy, a procedure which has a high rate of mortality. Researchers found that the one...

JANS Article

Long-Term Quality of Life After Esophagectomy for Esophageal Cancer

February 9, 2023 | Cameron LindSilver Contributor

To understand the shift toward nonsurgical management of esophageal cancer, researchers set out to determine the long-term quality of life (QOL) after esophagectomy. This study found that, in esophagectomy patients...

JANS Article

Global Thoracic Surgery

August 27, 2022 | Emily FarkasBronze Contributor

The delivery of thoracic surgical care in less-resourced areas is explored in this landmark series of articles, hoping to engage the thoracic surgeon in global health equity. There is a...

JANS Article

Long-Term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma

August 12, 2021 | Mark FergusonBronze Contributor

Although the standard of care in the West for regionally advanced esophageal cancer entails induction therapy, this is routinely not the case in China. This randomized trial involving over 450...

JANS Article

Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer

June 25, 2021 | Mark FergusonBronze Contributor

Data from the Esodata project used more than 8,000 patients undergoing esophagectomy for cancer to develop a risk prediction score for 90-day mortality. Development and validation groups were used. There...

JANS Article

Chyle Leak Following Radical En Bloc Esophagectomy with Two-Field Nodal Dissection: Predisposing Factors, Management, and Outcomes

June 10, 2021 | Mark FergusonBronze Contributor

Chyle leak remains a challenging postoperative complication to manage, and avoidance is always easier than mitigation. The only predisposing factor identified in this study was low BMI. Although ICU stay...

JANS Article

Implementation of Minimally Invasive Esophagectomy From a Randomized Controlled Trial Setting to National Practice

June 27, 2020 | Mark FergusonBronze Contributor

The previous randomized study of minimally invasive esophagectomy vs open esophagectomy (TIME trial) conducted in the Netherlands demonstrated reduced pulmonary complications and LOS with MIE. Compared to the benefits of...

JANS Article

AI Better Than GI?

November 26, 2019 | Mark FergusonBronze Contributor

A deep-learning computer aided detection (CAD) system was trained to recognize neoplasia using nearly 500,000 endoscopic images. In head-to-head testing against experienced gastroenterologists using additional images, the accuracy of CAD...

JANS Article

Analysis of the National Cancer Database Esophageal Squamous Cell Carcinoma in the United States

October 24, 2019 | Mark FergusonBronze Contributor

The National Cancer Database was queried regarding esophageal squamous cancer cases from 2004-2013, and over 11,000 patients were identified. Definitive chemoradiotherapy was used in 79%, whereas resection was employed in...

JANS Article

Adjuvant Therapy for Node-Positive Esophageal Cancer After Induction and Surgery: A Multisite Study

August 22, 2019 | Mark FergusonBronze Contributor

In this multiinstitutional retrospective study, administration of adjuvant chemotherapy for patients with persistent nodal disease after induction therapy and esophagectomy was associated with improved survival.

...
JANS Article

Association of Discretionary Hospital Volume Standards for High-Risk Cancer Surgery With Patient Outcomes and Access, 2005-2016

August 15, 2019 | Mark FergusonBronze Contributor

Regionalization of care for complex problems remains an open question in most countries. This review demonstrated that, for high risk cancer operations in the US, the Leapfrog group’s volume standards...

LOAD MORE
ADVERTISE ON CTSNET